ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis
Open Access
- 21 September 2023
- journal article
- research article
- Published by Springer Nature in Human Genomics
- Vol. 17 (1) , 1-15
Abstract
Background: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease, with unclear pathogenesis. Although immune disorders, especially T cell infiltration, are thought to play a vital role in PSC, the specific pathogenesis mechanisms remain incompletely understood. This study evaluated the potential key gene associated with the PSC pathogenesis and analyzed the associations of the key gene with prognosis and immune cell infiltration by combining bioinformatics analysis and experimental verification. Methods: Transcriptome data of PSC and normal human liver tissues (GSE159676) were obtained from the gene expression omnibus database. Differentially expressed genes (DEGs) were identified, and differences in biological states were analyzed. A protein–protein interaction (PPI) network was constructed. Hub genes were identified, and their expression was verified using transcriptome data of mice fed 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) and Mdr2−/− mice (GSE179993, GSE80776), as well as by immunohistochemistry staining on clinical samples. The correlations between the key gene and other factors were evaluated by Pearson’s correlation coefficient. Immune cell infiltration into human liver (GSE159676) was analyzed by xCell and verified by immunofluorescence staining on PSC liver samples. Results: Of the 185 DEGs identified, 113 were upregulated and 72 were downregulated genes in PSC. Genes associated with immune cell infiltration and fibrosis were significantly enriched in PSC. PPI network showed close interactions among DEGs. A module strongly associated with immune infiltration was identified, with annexin A1 (ANXA1) being the core gene. High expression of ANXA1 in PSC was confirmed in two public datasets and by immunohistochemistry staining on clinical samples. High ANXA1 expression was strongly associated with high-risk score for PSC. Also, ANXA1 expression was positively associated with chemokines and chemokine receptors and with the infiltration of immune cells, especially T cells, into liver with PSC. Immune infiltration, fibrosis, and cancer-related processes were markedly enriched in PSC with high expression of ANXA1. Conclusion: ANXA1 is a key gene associated with high risk and infiltration of immune cells, especially T cells, in PSC. These findings provide new insight into the key biomarker of PSC and suggest that targeting ANXA1 may be a valuable strategy for the treatment of PSC.Keywords
Funding Information
- National Natural Science Foundation of China (81974080, 82170640)
- WANG Bao-En Liver Fibrosis Research Fund (2021039)
- Research and Development Plan in Key Areas of Science and Technology Department of Hunan Province (2020SK30272)
This publication has 60 references indexed in Scilit:
- NCBI GEO: archive for functional genomics data sets--10 years onNucleic Acids Research, 2010
- Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitisSeminars in Immunopathology, 2009
- Impaired T cell activation and increased Th2 lineage commitment in Annexin‐1‐deficient T cellsEuropean Journal of Immunology, 2007
- A New Xenobiotic-Induced Mouse Model of Sclerosing Cholangitis and Biliary FibrosisThe American Journal of Pathology, 2007
- Annexin-1 modulates T-cell activation and differentiationBlood, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Gene map of the extended human MHCNature Reviews Genetics, 2004
- Hepatic Endothelial CCL25 Mediates the Recruitment of CCR9+ Gut-homing Lymphocytes to the Liver in Primary Sclerosing CholangitisJournal of Experimental Medicine, 2004
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- A Revised Natural History Model for Primary Sclerosing CholangitisMayo Clinic Proceedings, 2000